LikeMinds

LikeMinds is a biotechnology company focused on developing a dopamine-transporter imaging agent aimed at the detection and treatment of dopamine-related brain disorders. The company's platform offers early, accurate, and actionable diagnoses for conditions such as Parkinson's Syndrome and dementia. By enabling physicians to identify these diseases more effectively, LikeMinds seeks to improve treatment outcomes for patients suffering from dopamine-related brain disorders.

Peter Savas

Founder, CEO and Chairman

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.